Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


News Briefs: Device Tax Repeal Update; Surgery Firms Merge; Medtronic’s Drug-Eluting Balloon

This article was originally published in The Gray Sheet

Executive Summary

House GOP freshman renew efforts to repeal the device tax. Minimally invasive surgery companies to merge. Medtronic submits the first module of the PMA for its drug-eluting balloon. More news.

You may also be interested in...

Quest Enters Market For BRCA Gene Testing

With the Oct. 15 launch of the BRCAvantage genetic test, Quest Diagnostics Inc. became the latest entrant into the now-competitive marketplace for BRCA diagnostic testing for the likelihood of inheriting breast or ovarian cancer.

People Briefs: New Executives At TearLab, SpectraScience And Pentax Medical

TearLab Corp. names president and chief operating officer. SpectraScience appoints chief financial officer. New global president named at Pentax Medical. Meanwhile, DJO Global’s chief financial officer departs, and the former HHS National Coordinator for Health Information Technology has joined Brookings Institution.

People Briefs: Changes At HHS IT Office, Escalon Medical, Baxano, And TransEnterix

Acting director of the HHS Office of the National Coordinator for Health Information Technology named. Escalon Medical leadership post handed down from father to son. Former Baxano Surgical CFO to become CFO at TransEnterix. More personnel news.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts